(MENAFN - Research Cosmos) Europe Interventional Oncology Market Overview:
Europe Interventional Oncology Market estimated at $ 522 million in 2018 and is expected to reach $ 816 million in 2025, increasing at a compound annual growth rate of 6 % over the 2018-2025 forecast period.
Interventional oncology is a branch of medical science that deals with minimally invasive medical procedures performed by interventional radiologists for the diagnosis, treatment and palliation of different types of cancer. Several image-guided techniques are used in this process such as computed tomography, fluoroscopy and ultrasound to diagnose and treat the specific site affected by pain or cancer. The interventional oncology procedure is performed more frequently with other treatments of cancer such as surgery, chemotherapy and radiotherapy.
Browse details of 140 number of pages research report developed on Europe Interventional Oncology Market Research Report @ https://www.researchcosmos.com/reports/europe-interventional-oncology-market/80293991
Europe Interventional Oncology Market Growth Drivers, Challenges and Opportunities
The growing demand for minimally invasive therapies is the main driver of the European market growth. These procedures could also be used to treat patients with other related comorbidities and inoperable patients. The ability of minimally invasive techniques to treat cancer cells better than alternative cancer treatments, such as radiotherapy, surgery and routine chemotherapy, has allowed this technique to gain popularity. In addition, health professionals and patients are progressively opting for minimally invasive procedures in the area of interventional oncology because of the advantages of such techniques, such as shorter hospital stay, minimal risk of infection, less complications, less pain and faster recovery time compared to conventional surgeries. These benefits of using minimally invasive procedures will stimulate the growth of the European interventional oncology market.
Interventional oncology is used to treat primary or metastatic cancer, such as liver cancer, kidney cancer, lung cancer, prostate cancer, breast cancer and pancreatic cancer. Most of these procedures are performed on an outpatient basis or require an overnight stay at the hospital. Due to its minimally invasive nature, the required recovery time and hospitalization are minimal. Some of the popular procedures are pain palliation, intra-arterial therapies, ablative therapies and neoadjuvant procedures.
Ask Free Sample of the Report @ https://www.researchcosmos.com/request/europe-interventional-oncology-market/80293991
Geographic Insights of Europe Interventional Oncology Market:
Europe is expected to represent the second largest share of the interventional oncology market due to a large population affected by chronic cancer, such as hepatocellular carcinoma, lung cancer, kidney cancer and metastatic colorectal cancer in its nations like the UK, Germany, France, Spain, Italy, and others.
Key market players:
Key players in the European interventional oncology market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BTG plc, AngioDynamics, Inc., Ethicon, Inc. (Johnson & Johnson), Merit Medical Systems, Inc. and Sirtex Medical Limited, Siemens Healthineers, Eckert & Ziegler BEBIG, Varian Medical Systems, Inc. and HealthTronics, Inc etc.
For any queries, inquire more @ https://www.researchcosmos.com/inquire/europe-interventional-oncology-market/80293991
Research Cosmos is a provider of standard and customized Industry research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending Industry reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Global Sales Manager
+1 888 709 8757